Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
Br J Clin Pharmacol ; 86(1): 175-181, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31658494

RESUMEN

Concentrations of drugs acting in the lungs are difficult to measure, resulting in relatively unknown local pharmacokinetics. The aim of this study is to assess the potential of exhaled breath condensate (EBC) as a matrix for pharmacokinetic analysis of inhaled and intravenous medication. A 4-way crossover study was conducted in 12 volunteers with tobramycin and salbutamol intravenously and via inhalation. EBC and plasma samples were collected postdose and analysed for drug concentrations. Sample dilution, calculated using urea concentrations, was used to estimate the epithelial lining fluid concentration. Salbutamol and tobramycin were largely undetectable in EBC after intravenous administration and were detectable after inhaled administration in all subjects in 50.8 and 51.5% of EBC samples, respectively. Correction of EBC concentrations for sample dilution did not explain the high variability. This high variability of EBC drug concentrations seems to preclude EBC as a matrix for pharmacokinetic analysis of tobramycin and salbutamol.


Asunto(s)
Albuterol , Tobramicina , Administración Intravenosa , Biomarcadores , Pruebas Respiratorias , Estudios Cruzados , Humanos
2.
Br J Clin Pharmacol ; 81(2): 256-68, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26852745

RESUMEN

AIM: The objective of this study was to investigate whether the pharmacokinetics of orally administered levofloxacin show 24 h variation. Levofloxacin was used as a model compound for solubility and permeability independent absorption and passive renal elimination. METHODS: In this single centre, crossover, open label study, 12 healthy subjects received an oral dose of 1000 mg levofloxacin at six different time points equally divided over the 24 h period. Population pharmacokinetic modelling was used to identify potential 24 h variation in the pharmacokinetic parameters of this drug. RESULTS: The pharmacokinetics of levofloxacin could be described by a one compartment model with first order clearance and a transit compartment to describe drug absorption. The fit of the model was significantly improved when the absorption rate constant was described as a cosine function with a fixed period of 24 h, a relative amplitude of 47% and a peak around 08.00 h in the morning. Despite this variation in absorption rate constant, simulations of a once daily dosing regimen showed that tmax , Cmax and the area under the curve at steady-state were not affected by the time of drug administration. CONCLUSION: The finding that the absorption rate constant showed considerable 24 h variation may be relevant for drugs with similar physicochemical properties as levofloxacin that have a narrower therapeutic index. Levofloxacin, however, can be dosed without taking into account the time of day, at least in terms of its pharmacokinetics.


Asunto(s)
Antibacterianos/farmacocinética , Ritmo Circadiano , Levofloxacino/farmacocinética , Modelos Biológicos , Administración Oral , Adolescente , Adulto , Antibacterianos/sangre , Antibacterianos/orina , Simulación por Computador , Estudios Cruzados , Relación Dosis-Respuesta a Droga , Electrocardiografía , Tasa de Filtración Glomerular , Humanos , Levofloxacino/sangre , Levofloxacino/orina , Masculino , Persona de Mediana Edad , Tirotropina/sangre , Adulto Joven
3.
ACS Infect Dis ; 10(3): 1000-1022, 2024 03 08.
Artículo en Inglés | MEDLINE | ID: mdl-38367280

RESUMEN

In this study, we identified three novel compound classes with potent activity against Plasmodium falciparum, the most dangerous human malarial parasite. Resistance of this pathogen to known drugs is increasing, and compounds with different modes of action are urgently needed. One promising drug target is the enzyme 1-deoxy-d-xylulose-5-phosphate synthase (DXPS) of the methylerythritol 4-phosphate (MEP) pathway for which we have previously identified three active compound classes against Mycobacterium tuberculosis. The close structural similarities of the active sites of the DXPS enzymes of P. falciparum and M. tuberculosis prompted investigation of their antiparasitic action, all classes display good cell-based activity. Through structure-activity relationship studies, we increased their antimalarial potency and two classes also show good metabolic stability and low toxicity against human liver cells. The most active compound 1 inhibits the growth of blood-stage P. falciparum with an IC50 of 600 nM. The results from three different methods for target validation of compound 1 suggest no engagement of DXPS. All inhibitor classes are active against chloroquine-resistant strains, confirming a new mode of action that has to be further investigated.


Asunto(s)
Antimaláricos , Malaria Falciparum , Tiazoles , Humanos , Plasmodium falciparum , Malaria Falciparum/tratamiento farmacológico , Malaria Falciparum/parasitología , Cloroquina , Antimaláricos/farmacología , Antimaláricos/química
5.
Chem Biol ; 15(8): 782-9, 2008 Aug 25.
Artículo en Inglés | MEDLINE | ID: mdl-18721749

RESUMEN

Lipases are successfully applied in enantioselective biocatalysis. Most lipases contain a lid domain controlling access to the active site, but Bacillus subtilis Lipase A (LipA) is a notable exception: its active site is solvent exposed. To improve the enantioselectivity of LipA in the kinetic resolution of 1,2-O-isopropylidene-sn-glycerol (IPG) esters, we replaced a loop near the active-site entrance by longer loops originating from Fusarium solani cutinase and Penicillium purpurogenum acetylxylan esterase, thereby aiming to increase the interaction surface for the substrate. The resulting loop hybrids showed enantioselectivities inverted toward the desired enantiomer of IPG. The acetylxylan esterase-derived variant showed an inversion in enantiomeric excess (ee) from -12.9% to +6.0%, whereas the cutinase-derived variant was improved to an ee of +26.5%. The enantioselectivity of the cutinase-derived variant was further improved by directed evolution to an ee of +57.4%.


Asunto(s)
Bacillus subtilis/enzimología , Lipasa/química , Lipasa/metabolismo , Ingeniería de Proteínas/métodos , Acetilesterasa/química , Acetilesterasa/genética , Secuencia de Aminoácidos , Sitios de Unión , Hidrolasas de Éster Carboxílico/química , Hidrolasas de Éster Carboxílico/genética , Evolución Molecular Dirigida , Lipasa/genética , Modelos Moleculares , Datos de Secuencia Molecular , Mutación , Conformación Proteica , Estereoisomerismo , Especificidad por Sustrato
6.
Chembiochem ; 9(7): 1110-5, 2008 May 05.
Artículo en Inglés | MEDLINE | ID: mdl-18383241

RESUMEN

In directed evolution experiments, success often depends on the efficacy of screening or selection methods. Genetic selections have proven to be extremely valuable for evolving enzymes with improved catalytic activity, improved stability, or with altered substrate specificity. In contrast, enantioselectivity is a difficult parameter to select for. In this study, we present a successful strategy that not only selects for catalytic activity, but for the first time also for enantioselectivity, as demonstrated by the selection of Bacillus subtilis lipase A variants with inverted and improved enantioselectivity. A lipase mutant library in an aspartate auxotroph Escherichia coli was plated on minimal medium that was supplemented with the aspartate ester of the desired enantiomer (S)-(+)-1,2-O-isopropylidene-sn-glycerol. To inhibit growth of less enantioselective variants, a covalently binding phosphonate ester of the opposite (R)-(-)-1,2-O-isopropylidene-sn-glycerol enantiomer was added as well. After three selection rounds in which the selection pressure was increased by raising the phosphonate ester concentration, a mutant was selected with an improved enantioselectivity increased from an ee of -29.6 % (conversion 23.4 %) to an ee of +73.1 % (conversion 28.9 %) towards the (S)-(+)-enantiomer. Interestingly, its amino acid sequence showed that the acid of the catalytic triad had migrated to a position further along the loop that connects beta7 and alphaE; this shows that the position of the catalytic acid is not necessarily conserved in this lipase.


Asunto(s)
Bacillus subtilis/enzimología , Evolución Molecular Dirigida/métodos , Lipasa/genética , Lipasa/metabolismo , Alquenos/metabolismo , Ácido Aspártico/metabolismo , Bacillus subtilis/genética , Escherichia coli/crecimiento & desarrollo , Escherichia coli/metabolismo , Regulación Bacteriana de la Expresión Génica , Biblioteca de Genes , Glicerol/análogos & derivados , Glicerol/metabolismo , Hidrólisis , Mutación , Periplasma/genética , Periplasma/metabolismo , Estereoisomerismo , Especificidad por Sustrato
7.
FEBS J ; 274(9): 2181-95, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17448143

RESUMEN

Enzymes have become an attractive alternative to conventional catalysts in numerous industrial processes. However, their properties do not always meet the criteria of the application of interest. Directed evolution is a powerful tool for adopting the characteristics of an enzyme. However, selection of the evolved variants is a critical step, and therefore new strategies to enable selection of the desired enzymatic activity have been developed. This review focuses on these novel strategies for selecting enzymes from large libraries, in particular those that are used in the synthesis of pharmaceutical intermediates and pharmaceuticals.


Asunto(s)
Evolución Molecular Dirigida/métodos , Enzimas/química , Enzimas/metabolismo , Biblioteca de Péptidos , Preparaciones Farmacéuticas/síntesis química , Preparaciones Farmacéuticas/metabolismo , Animales , Catálisis , Enzimas/fisiología , Humanos , Especificidad por Sustrato
8.
Menopause ; 14(3 Pt 1): 474-80, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17237734

RESUMEN

OBJECTIVE: This study was conducted to establish whether 7alpha-methyl-ethinyl estradiol (7alpha-MEE) in plasma from postmenopausal women treated with tibolone is a metabolite or an artifact. DESIGN: Clinical samples with known levels of tibolone metabolites, plus plasma samples spiked with tibolone and metabolites, were analyzed for levels of 7alpha-MEE using liquid chromatography-mass spectometry (LC-MS/MS) with and without derivatization. RESULTS: Approximately 20 to 40 pg/mL 7alpha-MEE was detected using LC-MS/MS with derivatization in plasma samples from postmenopausal women treated with tibolone. In plasma samples spiked with 200 ng/mL tibolone or Delta-tibolone, LC-MS/MS with derivatization revealed the generation of around 200 and 36 pg/mL 7alpha-MEE, respectively, whereas LC-MS/MS without derivatization showed no detectable chemical conversion of tibolone to 7alpha-MEE. Generation of 7alpha-MEE is increased by the "stress conditions" used in the derivatization procedure; simply drying the sample also shows this artifactual conversion. The major active and sulfated 3-hydroxy metabolites of tibolone are not converted to 7alpha-MEE. Without derivatization, and avoiding stress conditions, no detectable levels (<20 pg/mL) of 7alpha-MEE were found in plasma samples from postmenopausal women treated with single (eight participants at 13 time points) or multiple (seven participants at 18 time points) doses of tibolone. CONCLUSIONS: 7alpha-MEE is not a metabolite of tibolone but is a chemical artifact generated during analytical procedures with derivatization. Using LC-MS/MS without derivatization, 7alpha-MEE cannot be demonstrated in plasma from postmenopausal women after single or multiple doses of tibolone.


Asunto(s)
Estradiol/análogos & derivados , Moduladores de los Receptores de Estrógeno/administración & dosificación , Moduladores de los Receptores de Estrógeno/química , Norpregnenos/administración & dosificación , Norpregnenos/química , Cromatografía Liquida , Estradiol/química , Moduladores de los Receptores de Estrógeno/metabolismo , Femenino , Cromatografía de Gases y Espectrometría de Masas , Humanos , Persona de Mediana Edad , Norpregnenos/metabolismo , Posmenopausia , Sensibilidad y Especificidad
9.
FEMS Microbiol Lett ; 225(2): 319-24, 2003 Aug 29.
Artículo en Inglés | MEDLINE | ID: mdl-12951259

RESUMEN

Bacillus subtilis secretes two lipases LipA and LipB into the culture medium. Both enzyme genes were differentially expressed depending on the growth conditions as determined by activity assays and Western blotting in B. subtilis mutant strains lipA, lipB, and the corresponding lipA/lipB double mutant. In minimal medium, LipA was produced at wild-type level in a lipB mutant, however, no LipB protein was detected in a lipA mutant. Interestingly, LipA was produced and secreted at wild-type level in rich medium, but the enzyme remained enzymatically inactive, presumably being caused by a shift of the growth medium to acid pH. Furthermore, expression of the lipase genes was studied using transcriptional fusions with the lacZ reporter gene. The expression of lipA was repressed by high amino acid concentrations, whereas the lipB gene expression remained unaffected.


Asunto(s)
Aminoácidos/metabolismo , Bacillus subtilis/enzimología , Bacillus subtilis/genética , Regulación Bacteriana de la Expresión Génica , Lipasa/genética , Lipasa/metabolismo , Western Blotting , Caprilatos/metabolismo , Electroforesis en Gel de Poliacrilamida , Eliminación de Gen , Genes Reporteros , Concentración de Iones de Hidrógeno , beta-Galactosidasa/metabolismo
10.
J Biotechnol ; 101(1): 19-28, 2003 Feb 27.
Artículo en Inglés | MEDLINE | ID: mdl-12523966

RESUMEN

Phage display can be used as a protein engineering tool to select proteins with desirable binding properties from a library of randomly constructed mutants. Here, we describe the development of this method for the directed evolution of Bacillus subtilis lipase A, an enzyme that has marked properties for the preparation of pharmaceutically relevant chiral compounds. The lipase gene was cloned upstream of the phage g3p encoding sequence and downstream of a modified g3p signal sequence. Consequently, the enzyme was displayed at the surface of bacteriophage fd as a fusion to its minor coat protein g3p. The phage-bound lipase was correctly folded and fully enzymatically active as determined from the hydrolysis of p-nitrophenylcaprylate with K(m)-values of 0.38 and 0.33 mM for the phage displayed and soluble lipase, respectively. Both soluble lipase and lipase expressed on bacteriophages reacted covalently with a phosphonate suicide inhibitor. The phage does not hamper lipase binding, since both soluble and phage-bound lipase have a similar half-life of inactivation of approximately 5 min. Therefore, we conclude that the Bacillus lipase can be functionally expressed on bacteriophages as a fusion to the phage coat protein g3p. The specific interaction with the suicide inhibitor offers a fast and reproducible method for the future selection of mutant enzymes with an enantioselectivity towards new substrates.


Asunto(s)
Bacillus subtilis/enzimología , Bacillus subtilis/genética , Bacteriófago M13/enzimología , Bacteriófago M13/genética , Lipasa/metabolismo , Fagos de Bacillus/enzimología , Fagos de Bacillus/genética , Bacillus subtilis/metabolismo , Células Cultivadas , Clonación Molecular , Inhibidores Enzimáticos/química , Regulación Bacteriana de la Expresión Génica , Regulación Enzimológica de la Expresión Génica , Isomerismo , Lipasa/química , Lipasa/genética , Organofosfonatos/química , Biblioteca de Péptidos , Unión Proteica , Ingeniería de Proteínas/métodos , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Especificidad por Sustrato
11.
Naunyn Schmiedebergs Arch Pharmacol ; 380(1): 67-77, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19255745

RESUMEN

In human bronchial epithelial (16HBE14o(-)) cells, CB(1) and CB(2) cannabinoid receptors are present, and their activation by the endocannabinoid virodhamine and the synthetic non-selective receptor agonist CP55,940 inhibits adenylyl cyclase and cellular interleukin-8 release. Here, we analyzed changes in intracellular calcium ([Ca2+](i)) evoked by Delta(9)-tetrahydrocannabinol (Delta(9)-THC), CP55,940, and virodhamine in 16HBE14o(-) cells. Delta(9)-THC induced [Ca2+](i) increase and a large transient [Ca2+](i) mobilization, the latter probably reflecting store-depletion-driven capacitative Ca2+ entry (CCE). In contrast, CP55,940 induced a rather moderate Ca2+ influx and a sustained [Ca2+](i) mobilization. CP55,940-induced Ca2+ influx was inhibited by Ni2+, indicating CCE, possibly mediated by transient receptor potential channel TRPC1, the mRNA of which is expressed in 16HBE14o(-) cells. CP55,940-induced calcium alterations were mimicked by virodhamine concentrations below 30 microM. Interestingly, higher virodhamine induced an additional Ca2+ entry, insensitive to Ni2+, but sensitive to the TRPV1 antagonist capsazepine, the TRPV1-TRPV4 inhibitor ruthenium red, and the non-CCE (NCCE) inhibitors La3+ and Gd3+. Such pharmacological profile is supported by the presence of TRPV1, TRPV4, and TRPC6 mRNAs as well as TRPV1 and TRPC6 proteins in 16HBE14o(-) cells. Cannabinoid receptor antagonists increased virodhamine-induced Ca2+ entry. Virodhamine also enhanced arachidonic acid release, which was insensitive to cannabinoid receptor antagonism, but sensitive to the phospholipase A(2) inhibitor quinacrine, and to capsazepine. Arachidonic acid induced [Ca2+](i) increase similar to virodhamine. Collectively, these observations suggest that [Ca2+](i) alterations induced by Delta(9)-THC, CP55,940 and by low concentrations of virodhamine involve mobilization and subsequent CCE mechanisms, whereas such responses by high virodhamine concentrations involve NCCE pathways.


Asunto(s)
Calcio/metabolismo , Moduladores de Receptores de Cannabinoides/farmacología , Cannabinoides/farmacología , Ácido Araquidónico/metabolismo , Ácidos Araquidónicos/administración & dosificación , Ácidos Araquidónicos/farmacología , Bronquios/citología , Bronquios/efectos de los fármacos , Bronquios/metabolismo , Moduladores de Receptores de Cannabinoides/administración & dosificación , Cannabinoides/administración & dosificación , Línea Celular , Ciclohexanoles/administración & dosificación , Ciclohexanoles/farmacología , Relación Dosis-Respuesta a Droga , Dronabinol/administración & dosificación , Dronabinol/farmacología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Humanos , ARN Mensajero/metabolismo , Canales Catiónicos TRPC/metabolismo
12.
Chembiochem ; 7(1): 149-57, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16342303

RESUMEN

Phage display can be used as a protein-engineering tool for the selection of proteins with desirable binding properties from a library of mutants. Here we describe the application of this method for the directed evolution of Bacillus subtilis lipase A, an enzyme that has important properties for the preparation of the pharmaceutically relevant chiral compound 1,2-O-isopropylidene-sn-glycerol (IPG). PCR mutagenesis with spiked oligonucleotides was employed for saturation mutagenesis of a stretch of amino acids near the active site. After expression of these mutants on bacteriophages, dual selection with (S)-(+)- and (R)-(-)-IPG stereoisomers covalently coupled to enantiomeric phosphonate suicide inhibitors (SIRAN Sc and Rc inhibitors, respectively) was used for the isolation of variants with inverted enantioselectivity. The mutants were further characterised by determination of their Michaelis-Menten parameters. The 3D structures of the Sc and Rc inhibitor-lipase complexes were determined and provided structural insight into the mechanism of enantioselectivity of the enzyme. In conclusion, we have used phage display as a fast and reproducible method for the selection of Bacillus lipase A mutant enzymes with inverted enantioselectivity.


Asunto(s)
Bacillus subtilis/enzimología , Proteínas Bacterianas/química , Evolución Molecular Dirigida/métodos , Inhibidores Enzimáticos/farmacología , Biblioteca de Péptidos , Fosfatos/farmacología , Bacillus subtilis/efectos de los fármacos , Proteínas Bacterianas/efectos de los fármacos , Proteínas Bacterianas/genética , Clonación Molecular , Cristalización , Cristalografía por Rayos X , Inhibidores Enzimáticos/química , Hidrólisis , Modelos Moleculares , Estructura Molecular , Mutación , Fosfatos/química , Conformación Proteica , Estructura Terciaria de Proteína , Estereoisomerismo , Relación Estructura-Actividad
13.
Appl Environ Microbiol ; 72(7): 4589-95, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16820448

RESUMEN

Using the phage display technology, a protein can be displayed at the surface of bacteriophages as a fusion to one of the phage coat proteins. Here we describe development of this method for fusion of an intracellular carboxylesterase of Bacillus subtilis to the phage minor coat protein g3p. The carboxylesterase gene was cloned in the g3p-based phagemid pCANTAB 5E upstream of the sequence encoding phage g3p and downstream of a signal peptide-encoding sequence. The phage-bound carboxylesterase was correctly folded and fully enzymatically active, as determined from hydrolysis of the naproxen methyl ester with Km values of 0.15 mM and 0.22 mM for the soluble and phage-displayed carboxylesterases, respectively. The signal peptide directs the encoded fusion protein to the cell membrane of Escherichia coli, where phage particles are assembled. In this study, we assessed the effects of several signal peptides, both Sec dependent and Tat dependent, on the translocation of the carboxylesterase in order to optimize the phage display of this enzyme normally restricted to the cytoplasm. Functional display of Bacillus carboxylesterase NA could be achieved when Sec-dependent signal peptides were used. Although a Tat-dependent signal peptide could direct carboxylesterase translocation across the inner membrane of E. coli, proper assembly into phage particles did not seem to occur.


Asunto(s)
Adenosina Trifosfatasas/metabolismo , Bacillus subtilis/enzimología , Proteínas Bacterianas/metabolismo , Bacteriófago M13/metabolismo , Carboxilesterasa/metabolismo , Proteínas de Escherichia coli/metabolismo , Proteínas de Transporte de Membrana/metabolismo , Bacillus subtilis/genética , Proteínas Bacterianas/genética , Bacteriófago M13/genética , Biotecnología/métodos , Proteínas de la Cápside/genética , Proteínas de la Cápside/metabolismo , Carboxilesterasa/genética , Señales de Clasificación de Proteína , Transporte de Proteínas , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Canales de Translocación SEC , Proteína SecA
14.
J Sep Sci ; 28(6): 501-5, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15881078

RESUMEN

An enantioselective gas chromatography (GC) method has been developed and validated for determination of the enantiomers of citronellol in kinetic resolution experiments. S-(-)-beta-Citronellol is a precursor of rose oxide. After solid-phase extraction (SPE) with ethyl acetate, the enantiomers of R-(+)-beta-citronellol and S-(-)-beta-citronellol and their corresponding acetate- and butyrate esters were separated through enantioselective GC respectively. The method was validated and found to be reproducible, specific, accurate, and precise. Analyte recoveries and detection limits were also determined. The applicability of this method was shown in a kinetic resolution experiment using lipase A of Bacillus subtilis.


Asunto(s)
Cromatografía de Gases/métodos , Monoterpenos/química , Monoterpenos Acíclicos , Enzimas/química , Enzimas/metabolismo , Estudios de Evaluación como Asunto , Cinética , Reproducibilidad de los Resultados , Estereoisomerismo
15.
J Cell Physiol ; 205(1): 58-67, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15887237

RESUMEN

Cannabinoid CB1-receptor stimulation in DDT1 MF-2 smooth muscle cells induces a rise in [Ca2+]i, which is dependent on extracellular Ca2+ and modulated by thapsigargin-sensitive stores, suggesting capacitative Ca2+ entry (CCE), and by MAP kinase. Non-capacitative Ca2+ entry (NCCE) stimulated by arachidonic acid (AA) partly mediates histamine H1-receptor-evoked increases in [Ca2+]i in DDT1 MF-2 cells. In the current study, both Ca2+ entry mechanisms and a possible link between MAP kinase activation and increasing [Ca2+]i were investigated. In the whole-cell patch clamp configuration, the CB-receptor agonist CP 55, 940 evoked a transient, Ca2+-dependent K+ current, which was not blocked by the inhibitors of CCE, 2-APB, and SKF 96365. AA, but not its metabolites, evoked a transient outward current and inhibited the response to CP 55,940 in a concentration-dependent manner. CP 55,940 induced a concentration-dependent release of AA, which was inhibited by the CB1 antagonist SR 141716. The non-selective Ca2+ channel blockers La3+ and Gd3+ inhibited the CP 55,940-induced current at concentrations that had no effect on thapsigargin-evoked CCE. La3+ also inhibited the AA-induced current. CP 55,940-induced AA release was abolished by Gd3+ and by phospholipase A2 inhibition using quinacrine; this compound also inhibited the outward current. The CP 55,940-induced AA release was strongly reduced by the MAP kinase inhibitor PD 98059. The data suggest that in DDT1 MF-2 cells, AA is an integral component of the CB1 receptor signaling pathway, upstream of NCCE and, via PLA2, downstream of MAP kinase.


Asunto(s)
Ácido Araquidónico/metabolismo , Calcio/metabolismo , Miocitos del Músculo Liso/metabolismo , Receptor Cannabinoide CB1/agonistas , Receptor Cannabinoide CB1/metabolismo , Señalización del Calcio/efectos de los fármacos , Línea Celular , Capacidad Eléctrica , Gadolinio/farmacología , Histamina/metabolismo , Lantano/farmacología , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Miocitos del Músculo Liso/efectos de los fármacos , Fosfolipasas A/metabolismo , Fosfolipasas A2
16.
Ophthalmic Res ; 35(3): 160-3, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12711844

RESUMEN

In homogenates of the human iris, the nonsteroidal anti-inflammatory drug (NSAID) S(+)flurbiprofen has been reported to inhibit cyclooxygenase-1 (COX-1) 70-fold more potently than in human whole blood. We hypothesized that this difference may be due to alternative splicing of COX-1 mRNA in the human iris or in whole blood. In this study, we have identified a similar COX-1 splice variant (COX-1SV) in both tissues with comparable COX-1/COX-1SV expression ratios. Therefore, we conclude that the difference in IC(50) values of S(+)flurbiprofen towards COX-1 in the human iris and human whole blood is not related to differences in the occurrence of spliced COX-1.


Asunto(s)
Empalme Alternativo , Iris/metabolismo , Isoenzimas/genética , Prostaglandina-Endoperóxido Sintasas/genética , ARN Mensajero/metabolismo , Anciano , Anciano de 80 o más Años , Sangre/metabolismo , Ciclooxigenasa 1 , Femenino , Humanos , Isoenzimas/metabolismo , Masculino , Proteínas de la Membrana , Persona de Mediana Edad , Prostaglandina-Endoperóxido Sintasas/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA